By John K. Waters
Mindset Medical, an Arizona-based digital health company, today announced FDA 510(k) clearance for its contactless pulse rate measurement device, the Informed Vital Core (IVC) App.
Read Now
By John K. Waters
eClinicalWorks announces the results of a recent survey conducted to identify key operational and clinical challenges healthcare professionals face and the opportunities to apply AI solutions to meet those challenges.
Read Now
By John K. Waters
Zimmer Biomet Holdings receives FDA approval for its Oxford Cementless Partial Knee, marking the introduction of the first cementless partial knee replacement implant in the U.S.
Read Now
By John K. Waters
Exactech announces first surgeries with its GPS Ankle guidance technology.
Read Now
By John K. Waters
Onymos unveils an upgraded version of its document processing tool, DocKnow, with a focus on addressing critical needs in the healthcare industry.
Read Now
By John K. Waters
GE HealthCare introduces the Pristina Via mammography system at the recent Radiological Society of North America’s (RSNA) Annual Meeting, against a backdrop of a global shortage of technologists and a rising demand for mammograms.
Read Now
By John K. Waters
Lunit a leading AI-powered cancer diagnostics and therapeutics company, unveiled research at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting showcasing the potential of its AI technology to predict immunotherapy outcomes for patients with rare cancers.
Read Now
By John K. Waters
French startup Ablatom, a specialist in laser-induced breakdown spectroscopy (LIBS) technology, has announced the deployment of the world's first biomedical LIBS microscope, ELM-XS-MED, at the Grenoble Alpes University Hospital (CHUGA).
Read Now
By John K. Waters
In a move that surprised the scientific community, DeepMind, a division of Google parent company Alphabet focused on developing general-purpose artificial intelligence technology, has released the source code and model weights for AlphaFold 3, its groundbreaking AI system for predicting molecular interactions.
Read Now
By John K. Waters
Tempus AI announces the clinical rollout of its Immune Profile Score (IPS) test, an advanced algorithmic biomarker designed to guide immunotherapy treatment decisions for patients with stage IV and metastatic solid tumors.
Read Now